Hims & Hers stock has experienced a significant decline, with some reports indicating a 63% drop over the past 6 months and a 78% fall from its peak. The company's stock price has been affected by various factors, including concerns over the safety of its peptides and a recent weight-loss pill launch that did not appear to boost the stock. Despite the decline, some investors and analysts see the current valuation as compelling and a potential buying opportunity.